Donald Abrams, MD

Email Donald
(415) 476-4082

1001 Potrero Ave
San Francisco, CA 94110

Visit CTSI Profile

  • Professor, UCSF School of Medicine

Biography

Donald I. Abrams, M.D. is chief of the Hematology-Oncology Division at San Francisco General Hospital, an integrative oncologist at the UCSF Osher Center for Integrative Medicine and Professor of Clinical Medicine at the University of California San Francisco. He graduated from Brown University in 1972 and from the Stanford University School of Medicine in 1977. After completing an Internal Medicine residency at the Kaiser Foundation Hospital in San Francisco, he became a fellow in Hematology-Oncology at the UCSF Cancer Research Institute in 1980. During his fellowship, Dr. Abrams spent eight months working in the retrovirology laboratory of Harold Varmus, M.D. during the time that the first cases of AIDS were being diagnosed. He subsequently returned to the clinical arena where he was one of the original clinician/investigators to recognize many of the early AIDS-related conditions. He conducted numerous clinical trials investigating conventional as well as complementary therapies in patients with HIV including therapeutic touch, Traditional Chinese Medicine interventions, medicinal mushrooms, medical marijuana and distant healing. His interest in botanical therapies led him to pursue a two-year Fellowship in the Program in Integrative Medicine at the University of Arizona which he completed in December 2004. His particular passion in the field involves nutrition and cancer. Since completing his Fellowship, Dr. Abrams has been providing Integrative Medicine consultation to people living with and beyond cancer at the UCSF Osher Center for Integrative Medicine. He co-edited an Oxford University Press textbook in Integrative Oncology with Andrew Weil, M.D.. He is a member of the NCI PDQ CAM Editorial Board. Dr. Abrams was President of the Society of Integrative Oncology in 2010.

Displaying 1 - 186 of 186

  1. Chao C, Silverberg MJ, Chen LH, Xu L, Martínez-Maza O, Abrams DI, Zha HD, Haque R, Said J. Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma. Leuk Lymphoma. 2017 Jun 13; 1-9. View on Pubmed
  2. Abrams D, McCulloch M, Cohen M, Liaw M, Silverman D, Wilson C. A Survey of Licensed Acupuncturists in the San Francisco Bay Area. Integr Cancer Ther. 2017 Jan 01; 1534735416684946. View on Pubmed
  3. Edman JS, Greeson JM, Roberts RS, Kaufman AB, Abrams DI, Dolor RJ, Wolever RQ. Perceived stress in patients with common gastrointestinal disorders: Associations with quality of life, symptoms, and disease management. Explore (NY). 2016 Dec 16. View on Pubmed
  4. Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro Oncol. 2016 Aug 30. View on Pubmed
  5. Abrams DI. Using Medical Cannabis in an Oncology Practice. Oncology (Williston Park). 2016 May; 30(5). View on Pubmed
  6. Abrams DI. Integrating cannabis into clinical cancer care. Curr Oncol. 2016 Mar; 23(2):S8-S14. View on Pubmed
  7. Dusek JA, Abrams DI, Roberts R, Griffin KH, Trebesch D, Dolor RJ, Wolever RQ, McKee MD, Kligler B. Patients Receiving Integrative Medicine Effectiveness Registry (PRIMIER) of the BraveNet practice-based research network: study protocol. BMC Complement Altern Med. 2016; 16(1):53. View on Pubmed
  8. Chao C, Xu L, Silverberg MJ, Martínez-Maza O, Chen LH, Castor B, Abrams DI, Zha HD, Haque R, Said J. Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival. AIDS. 2015 Sep 24; 29(15):1943-51. View on Pubmed
  9. Andreae MH, Carter GM, Shaparin N, Suslov K, Ellis RJ, Ware MA, Abrams DI, Prasad H, Wilsey B, Indyk D, Johnson M, Sacks HS. Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. J Pain. 2015 Dec; 16(12):1221-32. View on Pubmed
  10. Wolever RQ, Goel NS, Roberts RS, Caldwell K, Kligler B, Dusek JA, Perlman A, Dolor R, Abrams DI. Integrative Medicine Patients Have High Stress, Pain, and Psychological Symptoms. Explore (NY). 2015 Jul-Aug; 11(4):296-303. View on Pubmed
  11. Abrams DI, Guzman M. Cannabis in cancer care. Clin Pharmacol Ther. 2015 Jun; 97(6):575-86. View on Pubmed
  12. Marcus JL, Chao C, Leyden WA, Xu L, Yu J, Horberg MA, Klein D, Towner WJ, Quesenberry CP, Abrams DI, Silverberg MJ. Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1167-73. View on Pubmed
  13. Chao C, Silverberg MJ, Xu L, Chen LH, Castor B, Martínez-Maza O, Abrams DI, Zha HD, Haque R, Said J. A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection. Clin Cancer Res. 2015 Mar 15; 21(6):1429-37. View on Pubmed
  14. Marcus JL, Chao CR, Leyden WA, Xu L, Klein DB, Horberg MA, Towner WJ, Quesenberry CP, Abrams DI, Van Den Eeden SK, Silverberg MJ. Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):495-502. View on Pubmed
  15. Abrams DI. Milking the evidence: diet does matter. J Clin Oncol. 2014 Aug 1; 32(22):2290-2. View on Pubmed
  16. Edman JS, Roberts RS, Dusek JA, Dolor R, Wolever RQ, Abrams DI. Characteristics of cancer patients presenting to an integrative medicine practice-based research network. Integr Cancer Ther. 2014 Sep; 13(5):405-10. View on Pubmed
  17. Wang CC, Silverberg MJ, Abrams DI. Non-AIDS-Defining Malignancies in the HIV-Infected Population. Curr Infect Dis Rep. 2014 Jun; 16(6):406. View on Pubmed
  18. Dhruva A, Hecht FM, Miaskowski C, Kaptchuk TJ, Bodeker G, Abrams D, Lad V, Adler SR. Correlating traditional Ayurvedic and modern medical perspectives on cancer: results of a qualitative study. J Altern Complement Med. 2014 May; 20(5):364-70. View on Pubmed
  19. Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, d'Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, Sabin CA. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study. BMC Infect Dis. 2013; 13:471. View on Pubmed
  20. Hazekamp A, Ware MA, Muller-Vahl KR, Abrams D, Grotenhermen F. The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms. J Psychoactive Drugs. 2013 Jul-Aug; 45(3):199-210. View on Pubmed
  21. Abrams DI, Dolor R, Roberts R, Pechura C, Dusek J, Amoils S, Amoils S, Barrows K, Edman JS, Frye J, Guarneri E, Kligler B, Monti D, Spar M, Wolever RQ. The BraveNet prospective observational study on integrative medicine treatment approaches for pain. BMC Complement Altern Med. 2013; 13:146. View on Pubmed
  22. Messina M, Caan BJ, Abrams DI, Hardy M, Maskarinec G. It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Oncology (Williston Park). 2013 May; 27(5):430-7. View on Pubmed
  23. Frenkel M, Abrams DI, Ladas EJ, Deng G, Hardy M, Capodice JL, Winegardner MF, Gubili JK, Yeung KS, Kussmann H, Block KI. Integrating dietary supplements into cancer care. Integr Cancer Ther. 2013 Sep; 12(5):369-84. View on Pubmed
  24. Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Quesenberry CP, Abrams DI, Silverberg MJ. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS. 2012 Nov 13; 26(17):2223-31. View on Pubmed
  25. Wolever RQ, Abrams DI, Kligler B, Dusek JA, Roberts R, Frye J, Edman JS, Amoils S, Pradhan E, Spar M, Gaudet T, Guarneri E, Homel P, Amoils S, Lee RA, Berman B, Monti DA, Dolor R. Patients seek integrative medicine for preventive approach to optimize health. Explore (NY). 2012 Nov-Dec; 8(6):348-52. View on Pubmed
  26. Rao MN, Schambelan M, Tai VW, Abrams DI, Khatami H, Havel PJ, Sakkas G, Mulligan K. Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men. AIDS Res Treat. 2012; 2012:103072. View on Pubmed
  27. Chao C, Silverberg MJ, Martínez-Maza O, Chi M, Abrams DI, Haque R, Zha HD, McGuire M, Xu L, Said J. Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma. Clin Cancer Res. 2012 Sep 1; 18(17):4702-12. View on Pubmed
  28. Abrams DI, Weil AT. What's the alternative? N Engl J Med. 2012 Jun 7; 366(23):2232-3; author reply 2233. View on Pubmed
  29. Dhruva A, Miaskowski C, Abrams D, Acree M, Cooper B, Goodman S, Hecht FM. Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomized controlled trial. J Altern Complement Med. 2012 May; 18(5):473-9. View on Pubmed
  30. Ackerman SL, Lown EA, Dvorak CC, Dunn EA, Abrams DI, Horn BN, Degelman M, Cowan MJ, Mehling WE. Massage for children undergoing hematopoietic cell transplantation: a qualitative report. Evid Based Complement Alternat Med. 2012; 2012:792042. View on Pubmed
  31. Mehling WE, Lown EA, Dvorak CC, Cowan MJ, Horn BN, Dunn EA, Acree M, Abrams DI, Hecht FM. Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trial. Evid Based Complement Alternat Med. 2012; 2012:450150. View on Pubmed
  32. Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Dubrow R, Quesenberry CP, Neugebauer RS, Abrams DI. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2551-9. View on Pubmed
  33. Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther. 2011 Dec; 90(6):844-51. View on Pubmed
  34. McCulloch M, Broffman M, van der Laan M, Hubbard A, Kushi L, Abrams DI, Gao J, Colford JM. Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods. Integr Cancer Ther. 2011 Sep; 10(3):240-59. View on Pubmed
  35. Chao C, Xu L, Abrams DI, Towner WJ, Horberg MA, Leyden WA, Silverberg MJ. HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons. AIDS. 2011 Sep 10; 25(14):1771-7. View on Pubmed
  36. Abrams DI, Couey P, Shade SB, Kelly ME, Kamanu-Elias N, Stamets P. Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC Complement Altern Med. 2011; 11:60. View on Pubmed
  37. Carter GT, Flanagan AM, Earleywine M, Abrams DI, Aggarwal SK, Grinspoon L. Cannabis in palliative medicine: improving care and reducing opioid-related morbidity. Am J Hosp Palliat Care. 2011 Aug; 28(5):297-303. View on Pubmed
  38. Lee J, Dibble S, Dodd M, Abrams D, Burns B. The relationship of chemotherapy-induced nausea to the frequency of pericardium 6 digital acupressure. Oncol Nurs Forum. 2010 Nov; 37(6):E419-25. View on Pubmed
  39. Chao C, Xu L, Abrams D, Leyden W, Horberg M, Towner W, Klein D, Tang B, Silverberg M. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS. 2010 Jul 17; 24(11):1765-70. View on Pubmed
  40. Messina M, Abrams DI, Hardy M. Can clinicians now assure their breast cancer patients that soyfoods are safe? Womens Health (Lond Engl). 2010 May; 6(3):335-8. View on Pubmed
  41. Abrams DI. Not soy simple. J Soc Integr Oncol. 2010; 8(1):1-2. View on Pubmed
  42. Silverberg MJ, Chao C, Abrams DI. New insights into the role of HIV infection on cancer risk. Lancet Oncol. 2009 Dec; 10(12):1133-4. View on Pubmed
  43. Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, Klein D, Quesenberry CP, Towner WJ, Abrams DI. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009 Nov 13; 23(17):2337-45. View on Pubmed
  44. Interleukin-2 therapy in patients with HIV infection. N Engl J Med. 2009 Oct 15; 361(16):1548-59. View on Pubmed
  45. Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009; 7(3):85-120. View on Pubmed
  46. Silverberg MJ, Abrams DI. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? Curr Opin HIV AIDS. 2009 Jan; 4(1):42-51. View on Pubmed
  47. Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS. 2008 Oct 18; 22(16):2143-53. View on Pubmed
  48. Lee J, Dodd MJ, Dibble SL, Abrams DI. Nausea at the end of adjuvant cancer treatment in relation to exercise during treatment in patients with breast cancer. Oncol Nurs Forum. 2008 Sep; 35(5):830-5. View on Pubmed
  49. Baker JV, Peng G, Rapkin J, Krason D, Reilly C, Cavert WP, Abrams DI, MacArthur RD, Henry K, Neaton JD. Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases. J Acquir Immune Defic Syndr. 2008 Aug 15; 48(5):541-6. View on Pubmed
  50. Lee J, Dodd M, Dibble S, Abrams D. Review of acupressure studies for chemotherapy-induced nausea and vomiting control. J Pain Symptom Manage. 2008 Nov; 36(5):529-44. View on Pubmed
  51. Baker JV, Peng G, Rapkin J, Abrams DI, Silverberg MJ, MacArthur RD, Cavert WP, Henry WK, Neaton JD. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS. 2008 Apr 23; 22(7):841-8. View on Pubmed
  52. Chou FY, Dodd M, Abrams D, Padilla G. Symptoms, self-care, and quality of life of Chinese American patients with cancer. Oncol Nurs Forum. 2007 Nov; 34(6):1162-7. View on Pubmed
  53. Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI. Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS. 2007 Sep 12; 21(14):1957-63. View on Pubmed
  54. Silverberg MJ, Abrams DI. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol. 2007 Sep; 19(5):446-51. View on Pubmed
  55. Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL. Vaporization as a smokeless cannabis delivery system: a pilot study. Clin Pharmacol Ther. 2007 Nov; 82(5):572-8. View on Pubmed
  56. Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007 Feb 13; 68(7):515-21. View on Pubmed
  57. Abrams DI, Shade SB, Couey P, McCune JM, Lo J, Bacchetti P, Chang B, Epling L, Liegler T, Grant RM. Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study. AIDS Res Hum Retroviruses. 2007 Jan; 23(1):77-85. View on Pubmed
  58. Deng GE, Cassileth BR, Cohen L, Gubili J, Johnstone PA, Kumar N, Vickers A. Integrative Oncology Practice Guidelines. J Soc Integr Oncol. 2007; 5(2):65-84. View on Pubmed
  59. Abrams DI. An overview of integrative oncology. Clin Adv Hematol Oncol. 2007 Jan; 5(1):45-7. View on Pubmed
  60. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006 Nov 30; 355(22):2283-96. View on Pubmed
  61. Astin JA, Stone J, Abrams DI, Moore DH, Couey P, Buscemi R, Targ E. The efficacy of distant healing for human immunodeficiency virus--results of a randomized trial. Altern Ther Health Med. 2006 Nov-Dec; 12(6):36-41. View on Pubmed
  62. Lawrence J, Hullsiek KH, Thackeray LM, Abrams DI, Crane LR, Mayers DL, Jones MC, Saldanha JM, Schmetter BS, Baxter JD. Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 study. J Acquir Immune Defic Syndr. 2006 Oct 1; 43(2):169-78. View on Pubmed
  63. Abrams DI. Community-based clinical trials in hiv: the contributions of Mathilde Krim. AIDS Patient Care STDS. 2006 Jul; 20(7):480-5. View on Pubmed
  64. Dhruva A, Cheng J, Kwong M, Luce JA, Abrams DI. Contrasts, conflicts, and change: A case in cultural oncology. J Support Oncol. 2006 Jun; 4(6):301-4. View on Pubmed
  65. Tedaldi EM, Chen L, Markowitz N, Kelly L, Abrams D. Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART. J Viral Hepat. 2005 Jul; 12(4):414-20. View on Pubmed
  66. Behler C, Shade S, Gregory K, Abrams D, Volberding P. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retroviruses. 2005 Mar; 21(3):200-6. View on Pubmed
  67. Carter GT, Weydt P, Kyashna-Tocha M, Abrams DI. Medicinal cannabis: rational guidelines for dosing. IDrugs. 2004 May; 7(5):464-70. View on Pubmed
  68. Markowitz N, Bebchuk JD, Abrams DI. Nadir CD4+ T cell count predicts response to subcutaneous recombinant interleukin-2. Clin Infect Dis. 2003 Oct 15; 37(8):e115-20. View on Pubmed
  69. Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, Kitahata MM, Krone M, Neilands TB, Brand RJ, Lederman MM, Martin JN. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS. 2003 Sep 5; 17(13):1907-15. View on Pubmed
  70. Lawrence J, Mayers DL, Hullsiek KH, Collins G, Abrams DI, Reisler RB, Crane LR, Schmetter BS, Dionne TJ, Saldanha JM, Jones MC, Baxter JD. Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus. N Engl J Med. 2003 Aug 28; 349(9):837-46. View on Pubmed
  71. Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003 Aug 19; 139(4):258-66. View on Pubmed
  72. Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI. Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. J Clin Pharmacol. 2002 Nov; 42(11 Suppl):82S-89S. View on Pubmed
  73. Eisenberg JN, Wade TJ, Hubbard A, Abrams DI, Leiser RJ, Charles S, Vu M, Saha S, Wright CC, Levy DA, Jensen P, Colford JM. Associations between water-treatment methods and diarrhoea in HIV-positive individuals. Epidemiol Infect. 2002 Oct; 129(2):315-23. View on Pubmed
  74. Emery S, Abrams DI, Cooper DA, Darbyshire JH, Lane HC, Lundgren JD, Neaton JD. The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT. Control Clin Trials. 2002 Apr; 23(2):198-220. View on Pubmed
  75. Kosel BW, Aweeka FT, Benowitz NL, Shade SB, Hilton JF, Lizak PS, Abrams DI. The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir. AIDS. 2002 Mar 8; 16(4):543-50. View on Pubmed
  76. Abrams DI, Bebchuk JD, Denning ET, Davey RT, Fox L, Lane HC, Sampson J, Verheggen R, Zeh D, Markowitz NP. Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059. J Acquir Immune Defic Syndr. 2002 Mar 1; 29(3):221-31. View on Pubmed
  77. Abrams D. Benefit of IL-2 therapy in HIV patients confirmed. Am Fam Physician. 2001 Jun 15; 63(12):2424. View on Pubmed
  78. Mulligan K, Tai VW, Algren H, Abrams DI, Leiser RJ, Lo JC, Schambelan M. Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy. J Acquir Immune Defic Syndr. 2001 Apr 15; 26(5):443-8. View on Pubmed
  79. MacArthur RD, Chen L, Mayers DL, Besch CL, Novak R, van den Berg-Wolf M, Yurik T, Peng G, Schmetter B, Brizz B, Abrams D. The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial. Control Clin Trials. 2001 Apr; 22(2):176-90. View on Pubmed
  80. Abrams D. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy. AIDS Read. 2001 Mar; 11(3):149-56. View on Pubmed
  81. Abrams DI. Potential interventions for HIV/AIDS wasting: an overview. J Acquir Immune Defic Syndr. 2000 Oct 1; 25 Suppl 1:S74-80. View on Pubmed
  82. Abrams DI, Steinhart C, Frascino R. Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life. Int J STD AIDS. 2000 Oct; 11(10):659-65. View on Pubmed
  83. Baxter JD, Mayers DL, Wentworth DN, Neaton JD, Hoover ML, Winters MA, Mannheimer SB, Thompson MA, Abrams DI, Brizz BJ, Ioannidis JP, Merigan TC. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 2000 Jun 16; 14(9):F83-93. View on Pubmed
  84. Eberly LE, Ohman PA, Neaton JD, Price RW, Abrams DI. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 2000 May 26; 14(8):995-1000. View on Pubmed
  85. El-Sadr WM, Luskin-Hawk R, Yurik TM, Walker J, Abrams D, John SL, Sherer R, Crane L, Labriola A, Caras S, Pulling C, Hafner R. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) Clin Infect Dis. 1999 Oct; 29(4):775-83. View on Pubmed
  86. Szekeres G, Rappoport C, Abrams D. Current challenges to HIV research. BETA. 1999 Apr; 12(2):22-7. View on Pubmed
  87. Abrams DI. Getting on with AIDS. Lancet. 1999 Jan 30; 353(9150):415. View on Pubmed
  88. Brosgart CL, Mitchell TF, Coleman RL, Dyner T, Stephenson KE, Abrams DI. Clinical experience and choice of drug therapy for human immunodeficiency virus disease. Clin Infect Dis. 1999 Jan; 28(1):14-22. View on Pubmed
  89. Cox LE, Rouff JR, Svendsen KH, Markowitz M, Abrams DI. Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. Health Soc Work. 1998 Nov; 23(4):290-7. View on Pubmed
  90. Wheeler DA, Gibert CL, Launer CA, Muurahainen N, Elion RA, Abrams DI, Bartsch GE. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 May 1; 18(1):80-5. View on Pubmed
  91. Abrams DI. Medical marijuana: tribulations and trials. J Psychoactive Drugs. 1998 Apr-Jun; 30(2):163-9. View on Pubmed
  92. Leiser RJ, Mitchell TF, Hahn J, Slome L, Abrams DI. Nurses' attitudes and beliefs toward assisted suicide in AIDS. J Assoc Nurses AIDS Care. 1998 Mar-Apr; 9(2):26-33. View on Pubmed
  93. Brosgart CL, Louis TA, Hillman DW, Craig CP, Alston B, Fisher E, Abrams DI, Luskin-Hawk RL, Sampson JH, Ward DJ, Thompson MA, Torres RA. A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 1998 Feb 12; 12(3):269-77. View on Pubmed
  94. Grant RM, Abrams DI. Not all is dead in HIV-1 graveyard. Lancet. 1998 Jan 31; 351(9099):308-9. View on Pubmed
  95. Torres RA, Neaton JD, Wentworth DN, Barr MR, Abrams D, Sherer R, Ward T, Sampson J. Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of < 500/mm3. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Clin Infect Dis. 1998 Jan; 26(1):85-90. View on Pubmed
  96. Deeks SG, Abrams DI. Genotypic-resistance assays and antiretroviral therapy. Lancet. 1997 May 24; 349(9064):1489-90. View on Pubmed
  97. Slome LR, Mitchell TF, Charlebois E, Benevedes JM, Abrams DI. Physician-assisted suicide and patients with human immunodeficiency virus disease. N Engl J Med. 1997 Feb 6; 336(6):417-21. View on Pubmed
  98. Saravolatz LD, Winslow DL, Collins G, Hodges JS, Pettinelli C, Stein DS, Markowitz N, Reves R, Loveless MO, Crane L, Thompson M, Abrams D. Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med. 1996 Oct 10; 335(15):1099-106. View on Pubmed
  99. Leiser RJ, Mitchell TF, Hahn JA, Abrams DI. The role of critical care nurses in euthanasia and assisted suicide. N Engl J Med. 1996 Sep 26; 335(13):972-3; author reply 973-4. View on Pubmed
  100. Burack JH, Cohen MR, Hahn JA, Abrams DI. Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1; 12(4):386-93. View on Pubmed
  101. Abrams DI. Current therapeutic options for Kaposi's sarcoma. Oncology (Williston Park). 1996 Jun; 10(6 Suppl):24-7; discussion 37-8. View on Pubmed
  102. Brosgart CL, Mitchell T, Charlebois E, Coleman R, Mehalko S, Young J, Abrams DI. Off-label drug use in human immunodeficiency virus disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 1; 12(1):56-62. View on Pubmed
  103. Goldman AI, Carlin BP, Crane LR, Launer C, Korvick JA, Deyton L, Abrams DI. Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1; 11(2):161-9. View on Pubmed
  104. Northfelt DW, Charlebois ED, Mirda MI, Child C, Kaplan LD, Abrams DI. Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1; 8(1):45-50. View on Pubmed
  105. Fleming TR, Neaton JD, Goldman A, DeMets DL, Launer C, Korvick J, Abrams D. Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 10 Suppl 2:S9-18. View on Pubmed
  106. Neaton JD, Wentworth DN, Rhame F, Hogan C, Abrams DI, Deyton L. Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Stat Med. 1994 Oct 15-30; 13(19-20):2107-25. View on Pubmed
  107. Abrams DI. Treatment options in zidovudine intolerance or failure. AIDS. 1994 Sep; 8 Suppl 3:S3-7. View on Pubmed
  108. Abrams DI, Goldman AI, Launer C, Korvick JA, Neaton JD, Crane LR, Grodesky M, Wakefield S, Muth K, Kornegay S. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med. 1994 Mar 10; 330(10):657-62. View on Pubmed
  109. Jacobson MA, Besch CL, Child C, Hafner R, Matts JP, Muth K, Wentworth DN, Neaton JD, Abrams D, Rimland D. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS. J Infect Dis. 1994 Feb; 169(2):384-94. View on Pubmed
  110. Cotton DJ, Powderly WG, Feinberg J, Abrams DI, Chaisson RE, Wheat LJ, Finkelstein DM, Tallman V, Zimmer B, Berzon R. Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials Group. Clin Infect Dis. 1993 Jun; 16(6):816-22; discussion 823-4. View on Pubmed
  111. Abrams DI, Mitchell TF, Child CC, Shiboski SC, Brosgart CL, Mass MM. Clofazimine as prophylaxis for disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis. 1993 Jun; 167(6):1459-63. View on Pubmed
  112. Oie S, Jacobson MA, Abrams DI. Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV) J Acquir Immune Defic Syndr. 1993 May; 6(5):531-3. View on Pubmed
  113. Jacobson MA, Owen W, Campbell J, Brosgart C, Abrams DI. Tolerability of combined ganciclovir and didanosine for the treatment of cytomegalovirus disease associated with AIDS. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S69-73. View on Pubmed
  114. Slome L, Moulton J, Huffine C, Gorter R, Abrams D. Physicians' attitudes toward assisted suicide in AIDS. J Acquir Immune Defic Syndr. 1992; 5(7):712-8. View on Pubmed
  115. Abraham C, Sheeran P, Spears R, Abrams D. Health beliefs and promotion of HIV-preventive intentions among teenagers: a Scottish perspective. Health Psychol. 1992; 11(6):363-70. View on Pubmed
  116. Shuman MA, Corash L, Abrams DI, Hittelman KJ. Retraction. Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med. 1991 Nov 21; 325(21):1487. View on Pubmed
  117. Northfelt DW, Kaplan LD, Abrams DI. Continuous, low-dose therapy with interferon-alpha for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpura. Am J Hematol. 1991 Nov; 38(3):238-9. View on Pubmed
  118. Abrams DI. Acquired immunodeficiency syndrome and related malignancies: a topical overview. Semin Oncol. 1991 Oct; 18(5 Suppl 7):41-5. View on Pubmed
  119. Kaplan LD, Kahn JO, Crowe S, Northfelt D, Neville P, Grossberg H, Abrams DI, Tracey J, Mills J, Volberding PA. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. J Clin Oncol. 1991 Jun; 9(6):929-40. View on Pubmed
  120. Hersh EM, Brewton G, Abrams D, Bartlett J, Galpin J, Gill P, Gorter R, Gottlieb M, Jonikas JJ, Landesman S. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. JAMA. 1991 Mar 27; 265(12):1538-44. View on Pubmed
  121. Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. BMJ. 1991 Jan 12; 302(6768):73-8. View on Pubmed
  122. Northfelt DW, Mayer A, Kaplan LD, Abrams DI, Hadley WK, Yajko DM, Herndier BG. The usefulness of diagnostic bone marrow examination in patients with human immunodeficiency virus (HIV) infection. J Acquir Immune Defic Syndr. 1991; 4(7):659-66. View on Pubmed
  123. Greenspan D, Greenspan JS, Overby G, Hollander H, Abrams DI, MacPhail L, Borowsky C, Feigal DW. Risk factors for rapid progression from hairy leukoplakia to AIDS: a nested case-control study. J Acquir Immune Defic Syndr. 1991; 4(7):652-8. View on Pubmed
  124. Abrams DI. Alternative therapies in HIV infection. AIDS. 1990 Dec; 4(12):1179-87. View on Pubmed
  125. Abrams DI. Clinical manifestations of HIV infection, including persistent generalized lymphadenopathy and AIDS-related complex. J Am Acad Dermatol. 1990 Jun; 22(6 Pt 2):1217-22. View on Pubmed
  126. Abrams DI. The relationship between Kaposi's sarcoma and intestinal parasites among homosexual males in the United States. J Acquir Immune Defic Syndr. 1990; 3 Suppl 1:S44-6. View on Pubmed
  127. Scitovsky AA, Cline MW, Abrams DI. Effects of the use of AZT on the medical care costs of persons with AIDS in the first 12 months. J Acquir Immune Defic Syndr. 1990; 3(9):904-12. View on Pubmed
  128. Jacobson MA, Abrams DI, Volberding PA, Bacchetti P, Wilber J, Chaisson RE, Crowe S, Howard W, Moss A. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. J Infect Dis. 1989 Jun; 159(6):1029-36. View on Pubmed
  129. Wurtz RM, Abrams D, Becker S, Jacobson MA, Mass MM, Marks SH. Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients. Lancet. 1989 Apr 29; 1(8644):955-6. View on Pubmed
  130. Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, Ziegler J, Volberding PA. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA. 1989 Feb 3; 261(5):719-24. View on Pubmed
  131. Abrams DI, Kuno S, Wong R, Jeffords K, Nash M, Molaghan JB, Gorter R, Ueno R. Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med. 1989 Feb 1; 110(3):183-8. View on Pubmed
  132. Kaplan LD, Abrams DI, Sherwin SA, Kahn J, Volberding PA. A phase I/II study of recombinant tumor necrosis factor and recombinant interferon gamma in patients with AIDS-related complex. Biotechnol Ther. 1989-1990; 1(3):229-36. View on Pubmed
  133. Kahn JO, Kaplan LD, Volberding PA, Ziegler JL, Crowe S, Saks SR, Abrams DI. Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trial. J Acquir Immune Defic Syndr. 1989; 2(3):217-23. View on Pubmed
  134. Abrams DI. The persistent lymphadenopathy syndrome and immune thrombocytopenic purpura in HIV-infected individuals. Immunol Ser. 1989; 44:323-43. View on Pubmed
  135. So YT, Holtzman DM, Abrams DI, Olney RK. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol. 1988 Sep; 45(9):945-8. View on Pubmed
  136. Abrams DI. The pre-AIDS syndromes. Asymptomatic carriers, thrombocytopenic purpura, persistent generalized lymphadenopathy, and AIDS-related complex. Infect Dis Clin North Am. 1988 Jun; 2(2):343-51. View on Pubmed
  137. Moran TA, Lovejoy N, Viele CS, Dodd MJ, Abrams DI. Informational needs of homosexual men diagnosed with AIDS or AIDS-related complex. Oncol Nurs Forum. 1988 May-Jun; 15(3):311-4. View on Pubmed
  138. Ammann AJ, Palladino MA, Volberding P, Abrams D, Martin NL, Conant M. Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and aids-related complex. J Clin Immunol. 1987 Nov; 7(6):481-5. View on Pubmed
  139. Schneider PA, Abrams DI, Rayner AA, Hohn DC. Immunodeficiency-associated thrombocytopenic purpura (IDTP). Response to splenectomy. Arch Surg. 1987 Oct; 122(10):1175-8. View on Pubmed
  140. Abrams DI, Volberding PA. Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol. 1987 Jun; 14(2 Suppl 2):43-7. View on Pubmed
  141. Kaplan LD, Wolfe PR, Volberding PA, Feorino P, Levy JA, Abrams DI, Kiprov D, Wong R, Kaufman L, Gottlieb MS. Lack of response to suramin in patients with AIDS and AIDS-related complex. Am J Med. 1987 Mar 23; 82(3 Spec No):615-20. View on Pubmed
  142. Greenspan D, Greenspan JS, Hearst NG, Pan LZ, Conant MA, Abrams DI, Hollander H, Levy JA. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis. 1987 Mar; 155(3):475-81. View on Pubmed
  143. Abrams DI. AIDS update--1987. Adv Alcohol Subst Abuse. 1987; 7(2):29-45. View on Pubmed
  144. Abrams DI, Kaplan LD, McGrath MS, Volberding PA. AIDS-related benign lymphadenopathy and malignant lymphoma: clinical aspects and virologic interactions. AIDS Res. 1986 Dec; 2 Suppl 1:S131-40. View on Pubmed
  145. Abrams DI, Volberding PA. Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol. 1986 Sep; 13(3 Suppl 2):43-7. View on Pubmed
  146. Kaplan L, Abrams D, Volberding P. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer Treat Rep. 1986 Sep; 70(9):1121-2. View on Pubmed
  147. Bloom EJ, Abrams DI, Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA. 1986 Jul 25; 256(4):491-3. View on Pubmed
  148. Abrams DI. Lymphadenopathy related to the acquired immunodeficiency syndrome in homosexual men. Med Clin North Am. 1986 May; 70(3):693-706. View on Pubmed
  149. Abrams DI, Dilley JW, Maxey LM, Volberding PA. Routine care and psychosocial support of the patient with the acquired immunodeficiency syndrome. Med Clin North Am. 1986 May; 70(3):707-20. View on Pubmed
  150. Nyberg DA, Jeffrey RB, Federle MP, Bottles K, Abrams DI. AIDS-related lymphomas: evaluation by abdominal CT. Radiology. 1986 Apr; 159(1):59-63. View on Pubmed
  151. Abrams DI. AIDS-related lymphadenopathy: the role of biopsy. J Clin Oncol. 1986 Feb; 4(2):126-7. View on Pubmed
  152. Jeffrey RB, Nyberg DA, Bottles K, Abrams DI, Federle MP, Wall SD, Wing VW, Laing FC. Abdominal CT in acquired immunodeficiency syndrome. AJR Am J Roentgenol. 1986 Jan; 146(1):7-13. View on Pubmed
  153. Bottles K, Cohen MB, Brodie H, Jeffrey RB, Nyberg DA, Abrams DI. Fine-needle aspiration cytology of lymphadenopathy in homosexual males. Diagn Cytopathol. 1986 Jan-Mar; 2(1):31-5. View on Pubmed
  154. Kiprov DD, Lippert R, Miller RG, Sandstrom E, Jones FR, Cohen RJ, Abrams D, Busch DF. The use of plasmapheresis, lymphocytapheresis, and staph protein-A immunoadsorption as an immunomodulatory therapy in patients with AIDS and AIDS-related conditions. J Clin Apher. 1986; 3(2):133-9. View on Pubmed
  155. Abrams DI, Kiprov DD, Goedert JJ, Sarngadharan MG, Gallo RC, Volberding PA. Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Ann Intern Med. 1986 Jan; 104(1):47-50. View on Pubmed
  156. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, Freese UK. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med. 1985 Dec 19; 313(25):1564-71. View on Pubmed
  157. Stricker RB, Abrams DI, Corash L, Shuman MA. Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med. 1985 Nov 28; 313(22):1375-80. View on Pubmed
  158. Lipkin WI, Parry G, Kiprov D, Abrams D. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology. 1985 Oct; 35(10):1479-83. View on Pubmed
  159. Volberding PA, Abrams DI, Conant M, Kaslow K, Vranizan K, Ziegler J. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Sep; 103(3):335-8. View on Pubmed
  160. Volberding P, Abrams D. Clinical care and research in AIDS. Hastings Cent Rep. 1985 Aug; 15(4):suppl 16-8. View on Pubmed
  161. Moss AR, Bacchetti P, Osmond D, Dritz S, Abrams D, Conant M, Volberding P, Ziegler J. Incidence of the acquired immunodeficiency syndrome in San Francisco, 1980-1983. J Infect Dis. 1985 Jul; 152(1):152-61. View on Pubmed
  162. Shannon K, Cowan MJ, Ball E, Abrams D, Volberding P, Ammann AJ. Impaired mononuclear-cell proliferation in patients with the acquired immune deficiency syndrome results from abnormalities of both T lymphocytes and adherent mononuclear cells. J Clin Immunol. 1985 Jul; 5(4):239-45. View on Pubmed
  163. Abrams DI, Kiprov DD, Volberding PA. Isolated thrombocytopenia in homosexual men--longitudinal follow-up. Adv Exp Med Biol. 1985; 187:117-22. View on Pubmed
  164. Abrams DI. Asymptomatic lymphadenopathy and other early presentations of AIDS. Front Radiat Ther Oncol. 1985; 19:59-65. View on Pubmed
  165. Kiprov DD, Lippert R, Sandstrom E, Jones FR, Cohen RJ, Abrams D, Busch DF. Acquired immunodeficiency syndrome (AIDS)--apheresis and operative risks. J Clin Apher. 1985; 2(4):427-40. View on Pubmed
  166. Moss AR, Abrams D, Conant M, Volberding P. Incidence of the acquired immunodeficiency syndrome in San Francisco. Front Radiat Ther Oncol. 1985; 19:14-20. View on Pubmed
  167. Abrams DI, Mess T, Volberding PA. Lymphadenopathy: end-point prodrome? Update of a 36-month prospective study. Adv Exp Med Biol. 1985; 187:73-84. View on Pubmed
  168. Volberding PA, Wofsy CB, Abrams DI. Interferon and interleukin-2 therapy of Kaposi's sarcoma. Adv Exp Med Biol. 1985; 187:151-7. View on Pubmed
  169. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen VH. Oral viral leukoplakia--a new AIDS-associated condition. Adv Exp Med Biol. 1985; 187:123-8. View on Pubmed
  170. Valone FH, Payan DG, Abrams DI, Dohlman JG, Goetzl EJ. Indomethacin enhances the proliferation of mitogen-stimulated T lymphocytes of homosexual males with persistent generalized lymphadenopathy. J Clin Immunol. 1984 Sep; 4(5):383-7. View on Pubmed
  171. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 30; 311(9):565-70. View on Pubmed
  172. Valone FH, Payan DG, Abrams DI, Goetzl EJ. Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. J Infect Dis. 1984 Aug; 150(2):267-71. View on Pubmed
  173. Lozada-Nur F, Silverman S, Migliorati C, Conant M, Abrams D, Volverding PA, Greenspan D. The diagnosis of AIDS and AIDS related complex in the dental office: findings in 171 homosexual males. CDA J. 1984 Jun; 12(6):21-5. View on Pubmed
  174. Abrams DI, Lewis BJ, Beckstead JH, Casavant CA, Drew WL. Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? Ann Intern Med. 1984 Jun; 100(6):801-8. View on Pubmed
  175. Abrams DI, Robia M, Blumenfeld W, Simonson J, Cohen MB, Hadley WK. Disseminated coccidioidomycosis in AIDS. N Engl J Med. 1984 Apr 12; 310(15):986-7. View on Pubmed
  176. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA. 1984 Mar 16; 251(11):1447-9. View on Pubmed
  177. Moon KL, Federle MP, Abrams DI, Volberding P, Lewis BJ. Kaposi sarcoma and lymphadenopathy syndrome: limitations of abdominal CT in acquired immunodeficiency syndrome. Radiology. 1984 Feb; 150(2):479-83. View on Pubmed
  178. Abrams DI, Chinn EK, Lewis BJ, Volberding PA, Conant MA, Townsend RM. Hematologic manifestations in homosexual men with Kaposi's sarcoma. Am J Clin Pathol. 1984 Jan; 81(1):13-8. View on Pubmed
  179. Ziegler JL, Bragg K, Abrams D, Beckstead J, Cogan M, Volberding P, Baer D, Wilkinson L, Rosenbaum E, Grant K. High-grade non-Hodgkin's lymphoma in patients with AIDS. Ann N Y Acad Sci. 1984; 437:412-9. View on Pubmed
  180. Abrams DI, Lewis BJ, Volberding PA. Lymphadenopathy: endpoint or prodrome? Update of a 24-month prospective study. Ann N Y Acad Sci. 1984; 437:207-15. View on Pubmed
  181. Jaffe HS, Abrams DI, Ammann AJ, Lewis BJ, Golden JA. Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet. 1983 Nov 12; 2(8359):1109-11. View on Pubmed
  182. Ammann AJ, Abrams D, Conant M, Chudwin D, Cowan M, Volberding P, Lewis B, Casavant C. Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol. 1983 Jun; 27(3):315-25. View on Pubmed
  183. Moss AR, Bacchetti P, Gorman M, Dritz S, Conant M, Abrams DI, Volberding P, Ziegler J. AIDS in the "gay" areas of San Francisco. Lancet. 1983 Apr 23; 1(8330):923-4. View on Pubmed
  184. Olson JA, Feinberg I, Silverman S, Abrams D, Greenspan JS. Serum vitamin B12, folate, and iron levels in recurrent aphthous ulceration. Oral Surg Oral Med Oral Pathol. 1982 Nov; 54(5):517-20. View on Pubmed
  185. Drew WL, Conant MA, Miner RC, Huang ES, Ziegler JL, Groundwater JR, Gullett JH, Volberding P, Abrams DI, Mintz L. Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet. 1982 Jul 17; 2(8290):125-7. View on Pubmed
  186. Drew WL, Conant MA, Miner RC, Huang ES, Ziegler JL, Groundwater JR, Gullett JH, Volberding P, Abrams DI, Mintz L. Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet. 1982 Jul 17; 2(8290):125-7. View on Pubmed